Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products - 24/04/13
Reprint requests: Henry W. Lim, MD, Department of Dermatology, Henry Ford Medical Center–New Center One, 3031 W Grand Blvd, Suite 800, Detroit, MI 48202.Abstract |
The Food and Drug Administration (FDA) regulates sunscreens as over-the-counter drugs. This article describes sunscreen actives available in the United States, new developments available elsewhere, and the amendment to the FDA 1999 sunscreen monograph, released on August 27, 2007, which proposes a new grading system for ultraviolet B protection, a cap of the sunburn protection factor to 50+, and a 4-star grading of ultraviolet A protection. In addition, current data on combination sunscreen and insect repellent products are discussed. Application of a combination product too frequently poses the risk of insect repellent toxicity, whereas application too infrequently invites photodamage. It may be prudent to follow the same approach of our Canadian colleagues of discontinuing combination products until more investigations are available.
Le texte complet de cet article est disponible en PDF.Abbreviations used : AAD, DEET, FDA, SPF, TEA, UV
Plan
| Funding sources: None. |
|
| Disclosure: Dr Lim is a consultant for La Roche-Posay, Orfagen, Johnson and Johnson, and Dow Pharmaceuticals, and he has received research grant support from Johnson and Johnson. Drs Hebert, Bangert, and Hexsel have no conflicts of interest to declare. |
Vol 59 - N° 2
P. 316-323 - août 2008 Retour au numéro
Article précédent
- Volunteers Needed
- Lower extremity lymphedema : Update: Pathophysiology, diagnosis, and treatment guidelines
- Katherine Kerchner, Anne Fleischer, Gil Yosipovitch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?